These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 21967664

  • 1. Vaginal progesterone after tocolytic therapy in threatened preterm labor.
    Bomba-Opon DA, Kosinska-Kaczynska K, Kosinski P, Wegrzyn P, Kaczynski B, Wielgos M.
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1156-9. PubMed ID: 21967664
    [Abstract] [Full Text] [Related]

  • 2. Effect of progesterone as a tocolytic and in maintenance therapy during preterm labor.
    Arikan I, Barut A, Harma M, Harma IM.
    Gynecol Obstet Invest; 2011 Jul; 72(4):269-73. PubMed ID: 22086108
    [Abstract] [Full Text] [Related]

  • 3. Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial.
    Borna S, Sahabi N.
    Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):58-63. PubMed ID: 18275573
    [Abstract] [Full Text] [Related]

  • 4. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B, Karolinski A, Ocampo MC, Laterra C, Hösli I, Fernández D, Surbek D, Huespe M, Drack G, Bunader A, Rouillier S, López de Degani G, Seidenstein E, Prentl E, Antón J, Krähenmann F, Nowacki D, Poncelas M, Nassif JC, Papera R, Tuma C, Espoile R, Tiberio O, Breccia G, Messina A, Peker B, Schinner E, Mol BW, Kanterewicz L, Wainer V, Boulvain M, Othenin-Girard V, Bertolino MV, Irion O, 4P trial group.
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [Abstract] [Full Text] [Related]

  • 5. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
    Stricker N, Timmesfeld N, Kyvernitakis I, Goerges J, Arabin B.
    Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
    [Abstract] [Full Text] [Related]

  • 6. Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis.
    Klein K, Rode L, Nicolaides KH, Krampl-Bettelheim E, Tabor A, PREDICT Group.
    Ultrasound Obstet Gynecol; 2011 Sep; 38(3):281-7. PubMed ID: 21739499
    [Abstract] [Full Text] [Related]

  • 7. Progesterone use after successful treatment of threatened pre-term delivery.
    Areia A, Fonseca E, Moura P.
    J Obstet Gynaecol; 2013 Oct; 33(7):678-81. PubMed ID: 24127952
    [Abstract] [Full Text] [Related]

  • 8. Tocolysis of preterm contractions does not improve preterm delivery rate or perinatal outcomes.
    Sciscione AC, Stamilio DM, Manley JS, Shlossman PA, Gorman RT, Colmorgen GH.
    Am J Perinatol; 1998 Mar; 15(3):177-81. PubMed ID: 9572373
    [Abstract] [Full Text] [Related]

  • 9. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
    O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, Soma-Pillay P, Porter K, How H, Schackis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572
    [Abstract] [Full Text] [Related]

  • 10. Cervical pessary plus vaginal progesterone versus long-term tocolysis for the prevention of preterm birth: An observational retrospective study.
    Tajima M, Yanazume S, Orita Y, Tazaki Y, Shinya M, Kobayashi H.
    Int J Gynaecol Obstet; 2020 Aug; 150(2):206-212. PubMed ID: 32282943
    [Abstract] [Full Text] [Related]

  • 11. Cervical dilatation on presentation for preterm labor and subsequent preterm birth.
    How HY, Khoury JC, Sibai BM.
    Am J Perinatol; 2009 Jan; 26(1):1-6. PubMed ID: 19021099
    [Abstract] [Full Text] [Related]

  • 12. [Progesterone for prevention of preterm delivery: only in trial setting].
    Lim AC, Mol BW, Bruinse HW.
    Ned Tijdschr Geneeskd; 2010 Jan; 154():A1730. PubMed ID: 20858311
    [Abstract] [Full Text] [Related]

  • 13. Early and late preterm delivery rates - a comparison of differing tocolytic policies in a single urban population.
    Hehir MP, O'Connor HD, Kent EM, Robson MS, Keane DP, Geary MP, Malone FD.
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2234-6. PubMed ID: 22524700
    [Abstract] [Full Text] [Related]

  • 14. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [Abstract] [Full Text] [Related]

  • 15. [Prevention of preterm birth with vaginal progesterone in women with preterm labor: which are the evidences?].
    Martinez de Tejada B, Othenin-Girard V, Irion O.
    Rev Med Suisse; 2015 Oct 28; 11(492):2004, 2006-8, 2010. PubMed ID: 26672179
    [Abstract] [Full Text] [Related]

  • 16. The impact of acute tocolysis on neonatal outcome in women hospitalized with preterm labor at 32 to 34 weeks' gestation.
    Elliott JP, Istwan NB, Rhea DJ, Desch CN, Stanziano GJ.
    Am J Perinatol; 2009 Feb 28; 26(2):123-8. PubMed ID: 18850519
    [Abstract] [Full Text] [Related]

  • 17. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
    Parry E, Roos C, Stone P, Hayward L, Mol BW, McCowan L.
    Aust N Z J Obstet Gynaecol; 2014 Jun 28; 54(3):231-6. PubMed ID: 24506318
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix.
    Pustotina O.
    J Matern Fetal Neonatal Med; 2018 Jul 28; 31(14):1830-1838. PubMed ID: 28502186
    [Abstract] [Full Text] [Related]

  • 19. [Progesterone for Prevention of Preterm Birth--Evidence-based Indications].
    Kuon RJ, Abele H, Berger R, Garnier Y, Maul H, Schleußner E, Rath W, Experts for the Prediction and Prevention of Preterm Birth (X4PB) – www.x4pb.de.
    Z Geburtshilfe Neonatol; 2015 Jun 28; 219(3):125-35. PubMed ID: 26114408
    [Abstract] [Full Text] [Related]

  • 20. The use of vaginal progesterone as a maintenance therapy in women with arrested preterm labor: a double-blind placebo-randomized controlled trial.
    Hyett J, Asadi N, Zare Khafri M, Vafaei H, Kasraeian M, Salehi A, Saadati N, Bazrafshan K.
    J Matern Fetal Neonatal Med; 2022 Mar 28; 35(6):1134-1140. PubMed ID: 32216490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.